Digitoxin in Heart Failure: A Statistical Signal, or Just Noise? A Reappraisal of the DIGIT-HF Trial
Abstract
A critical reappraisal of the DIGIT-HF trial examining whether the cardiovascular signals observed with digitoxin in heart failure patients represent genuine clinical benefit or statistical artifact.
Type
Publication
European Heart Journal - Cardiovascular Pharmacotherapy